RenieEBressinckMD

PubMed

• 32 citations
  Mometasone furoate 0.1%—salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study
  John Koo, Cynthia A. Cuffie, Daniel J. Tanner, Renie Bressinck, Roger C. Cornell, Richard L. DeVillez, Libby Edwards, Debra L. Breneman, Daniel Piacquadio, Cynthia Guz...> ;Clinical Therapeutics. 1998 Mar 1
• 23 citations
  Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.
  H.Irving Katz, Jane S. Lindholm, Jonathan S. Weiss, Joel S. Shavin, Manuel R. Morman, Renie Bressinck, Roger C. Cornell, David M. Pariser, Robert J. Pariser, Wayne Wen...> ;Clinical Therapeutics. 1995 May 1
• Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial.
  Papp, K. A., Bressinck, R., Fretzin, S., Goffe, B., Kempers, S., Gordon, K. B., Caro, I., Walicke, P. A., Wang, X., Menter, A.> ;Int J Dermatol. 2006 May
• Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent an...
  Medansky, R. S., Bressinck, R., Cole, G. W., Deeken, J. H., Ellis, C. N., Guin, J. D., Herndon, J. H., Lasser, A. E., Leibsohn, E., Menter, M. A.> ;Cutis. 1988 Nov
• Join now to see all